Sinopharm Tech Holdings Limited announced that Mr. HSU Dong An has been appointed as an independent non-executive Director of the Company, the chairperson of the nomination committee and a member of the audit committee, the remuneration committee and the nomination committee of the Company with effect from 15 August 2023. Mr. HSU Dong An, aged 34, has been a director of a subsidiary of a listed Company in Hong Kong since July 2021. He has over 11 years of experience in the field of corporate finance, financial management and audit experience in Hong Kong and the People's Republic of China.

From April 2013 to June 2021, Mr. HSU was a vice president of corporate finance of a previously listed Company in Hong Kong. Mr. HSU is a CFA charterholder of the CFA Institute. He graduated from the University of Southern California with a bachelor's degree in Accounting in 2011.